Visit https://www.peervoice.com/DHB860 to view the entire programme with slides. After completing “The First Biologic in IBD: When, Which, and Why?”, participants will be able to: Describe the clinical features and treatment goals of inflammatory bowel disease (IBD); Identify patient and drug characteristics that may influence treatment decision-making for patients with IBD; Formulate individualised treatment plans for patients with IBD who require biologic treatment, considering patient-specific factors.